Sun Nuclear Bolsters Radiation Therapy Innovation with Acquisition of AI-Powered Oncospace

Sun Nuclear, a subsidiary of Mirion Medical, has announced the acquisition of Oncospace, a provider of cloud-based, AI-driven solutions for radiation oncology. This strategic move underscores Sun Nuclear's commitment to leveraging cutting-edge technology to improve treatment outcomes for their customers. Oncospace, which was founded in 2018, offers two primary solutions that utilize AI and machine learning to optimize patient outcomes. These technologies are designed to be data-driven and physician-centric, addressing the specific needs of radiation oncology professionals. By harnessing essential information, Oncospace's products enhance the precision and efficiency of radiation therapy planning, ultimately improving the quality of care and patient outcomes. Luis Rivera, president of Sun Nuclear and executive vice president of Mirion Medical, expressed enthusiasm about the acquisition. "We are thrilled to welcome Oncospace into the Sun Nuclear family," he said. "Integrating Oncospace's AI and machine learning capabilities into our existing platform strengthens our commitment to driving innovation in radiation therapy. We anticipate significant positive impacts on our software development and look forward to showcasing these advancements." This acquisition aligns with Sun Nuclear's broader goal of enhancing radiation therapy quality and accessibility, ensuring that patients receive the most effective treatments. The company plans to integrate Oncospace's solutions into its brand, expanding its digital-forward strategy to offer comprehensive, cutting-edge quality assurance tools. Oncospace's software will make its debut at Sun Nuclear’s booth during ESTRO 2025, which runs from May 2 to May 6 in Vienna, Austria. ESTRO, the annual congress of the European Society for Radiotherapy and Oncology, features Europe’s largest industry exhibition dedicated to radiation oncology. Attendees will have the opportunity to see how these new technologies can revolutionize radiation therapy practices. Sun Nuclear, as part of the Mirion Medical group, is a leading provider of innovative solutions for radiation therapy and diagnostic imaging centers. Over 6,000 cancer centers globally rely on Sun Nuclear for independent, integrated quality management. The company is dedicated to ongoing support, aiming to simplify technology adoption, streamline workflows, and improve clinical outcomes. This focus ensures that healthcare providers can deliver the highest level of patient safety and care. For more information about Sun Nuclear and their latest developments, visit their website at sunnuclear.com.